Building on more than two decades of research, a study by MIT neuroscientists at The Picower Institute for Learning and ...
MIT neuroscientists have made a breakthrough in treating fragile X syndrome by leveraging a novel neurotransmitter signaling ...
MIT researchers suggests a potential molecular strategy for treating fragile X syndrome by enhancing NMDA subunit function.
In 2011, Bear's lab showed that fragile X and another autism disorder, tuberous sclerosis (Tsc), represented two ends of a continuum of a kind of protein synthesis in the same neurons. In fragile ...
1 天
AZoLifeSciences on MSNTargeting NMDA Receptor Subunit Shows Promise for Fragile X SyndromeBuilding on more than two decades of research, a study by MIT neuroscientists at The Picower Institute for Learning and Memory reports a new way to treat pathology and symptoms of fragile X syndrome, ...
10 天
GlobalData on MSNSpinogenix reports top line outcomes from trial of therapy for Fragile X syndromeUS-based biopharmaceutical company Spinogenix has published top line outcomes from a Phase II trial of SPG601 for treating ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果